Article citationsMore>>
Damm-Welk, C., Mussolin, L., Zimmermann, M., Pillon, M., Klapper, W., Oschlies, I., d’Amore, E.S., Reiter, A., Woessmann, W. and Rosolen, A. (2014) Early Assessment of Minimal Residual Disease Identifies Patients at Very High Relapse Risk in NPM-ALK-Positive Anaplastic Large-Cell Lymphoma. Blood, 123, 334-337.
https://doi.org/10.1182/blood-2013-09-526202
has been cited by the following article:
-
TITLE:
Brentuximab Vedotin Monotherapy and Combined with Low Dose Donor Lymphocyte Infusion to Control Minimal Residual Disease and Sustain Clinical Remission in a Child with Relapsed Anaplastic Large Cell Lymphoma
AUTHORS:
Alina S. Fedorova, Maria V. Stegantseva, Nina V. Minakovskaya, Olga V. Aleinikova
KEYWORDS:
Anaplastic Large Cell Lymphoma, Relapse, Brentuximab Vedotin, Donor Lymphocyte Infusion, Minimal Residual Disease
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.8 No.8,
July
28,
2017
ABSTRACT: Minimal
residual disease (MRD) appears to have a strong negative predictive value for
disease recurrence in children with anaplastic large cell lymphoma (ALCL).
Brentuximab vedotin (BV) can be a therapeutic option for MRD-positive
patients to achieve molecular remission and to decrease risk of subsequent
relapse. We here report a 4-year-old child with ALCL progression during relapse
treatment who received BV as a bridging therapy before haploidentical
hematopoietic stem-cell transplantation, and as a maintenance therapy
post-transplant alone or combined with simultaneous low dose donor-lymphocyte
infusions. MRD monitoring showed a complete molecular response and reflected
both BV efficiency and graft-versus-lymphoma effect.
Related Articles:
-
Jalel Chemli, Saida Hassayoun, Soumaya Ketata, Ajmi Houda, Moncef Mokni, Noura Zouari, Saoussen Abroug, Abdelaziz Harbi
-
Imane Ouafki, Tanae Sghiri, Saber Boutayeb, Mohamed Mouanis, Mustapha Maher, Hind Mrabti, Hassan Errihani
-
Ratha Mlis, Matthias Schell, Perrine Marec Bérard, Nathalie Bleyzac, Didier Frappaz
-
Ghada Ezzat Eladawei, Sheref Mohamed El-Taher
-
Sarah Tasneem, Lester Lipsky, Reda Ammar, Howard Sholl